Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4762272
Max Phase: Preclinical
Molecular Formula: C52H71N11O11S
Molecular Weight: 1058.27
Molecule Type: Unknown
Associated Items:
ID: ALA4762272
Max Phase: Preclinical
Molecular Formula: C52H71N11O11S
Molecular Weight: 1058.27
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(N)=O
Standard InChI: InChI=1S/C52H71N11O11S/c1-28(2)43(45(55)67)62-51(73)41(27-75)61-49(71)38(23-31-17-19-33(64)20-18-31)58-47(69)37(16-10-11-21-53)57-50(72)40(24-32-26-56-36-15-9-8-14-34(32)36)59-48(70)39(22-30-12-6-5-7-13-30)60-52(74)44(29(3)4)63-46(68)35(54)25-42(65)66/h5-9,12-15,17-20,26,28-29,35,37-41,43-44,56,64,75H,10-11,16,21-25,27,53-54H2,1-4H3,(H2,55,67)(H,57,72)(H,58,69)(H,59,70)(H,60,74)(H,61,71)(H,62,73)(H,63,68)(H,65,66)/t35-,37-,38-,39-,40-,41-,43-,44-/m0/s1
Standard InChI Key: REIJWEGIIFXBKT-LXJAOZTISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1058.27 | Molecular Weight (Monoisotopic): 1057.5055 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Bandholtz S,Erdmann S,von Hacht JL,Exner S,Krause G,Kleinau G,Grötzinger C. (2016) Urolinin: The First Linear Peptidic Urotensin-II Receptor Agonist., 59 (22.0): [PMID:27791374] [10.1021/acs.jmedchem.6b00164] |
Source(1):